A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma
Clinical trial NCT06799676 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06799676
- Sponsor
- Fuling Zhou
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2027-08-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.